Get the Stockscreener App
14.31
2.05%
-0.30
Hutchmed China Limited Adr Stock (HCM) Forecast
The Hutchmed China Limited Adr (HCM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $17.91, representing a +25.15% increase from the current price of $14.31. The highest analyst price target is $20.11, and the lowest is $15.71.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HCM Price Target
Average 18.52
(+29.40% Upside)
Is Hutchmed China Limited Adr (HCM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 28.87 | Buy |
| STOCH(9,6) | 6.2973 | Buy |
| STOCHRSI(14) | 8.4399 | Buy |
| MACD(12,26) | -0.9134 | Sell |
| ADX(14) | 22.33 | Neutral |
| William %R | -92.11 | Buy |
| CCI(14) | -115.76 | Sell |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
15.53
Sell
|
15.32
Sell
|
| MA20 |
16.42
Sell
|
16.09
Sell
|
| MA50 |
17.88
Sell
|
17.21
Sell
|
| MA100 |
18.12
Sell
|
17.73
Sell
|
| MA200 |
18.14
Sell
|
17.70
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, HCM could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on HCM, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 28.87 indicates that HCM is oversold. This indicates that HCM price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 6.2973 indicates that HCM is oversold. This indicates that HCM price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 8.4399 indicates that HCM is oversold. This suggests that HCM price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.33 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -115.76 indicates that HCM is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term HCM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Hutchmed China Limited Adr financial reports and earnings history, Hutchmed China Limited Adr (HCM) stock could reach $15.29 by 2030, $2.188 by 2040 and $7.7824 by 2050. See the projected annual prices until 2050 of the Hutchmed China Limited Adr stock below:
- Hutchmed China Limited Adr (HCM) is expected to reach an average price of $9.0405 in 2035, with a high prediction of $10.47 and a low estimate of $7.1285. This indicates an $-36.82% rise from the last recorded price of $14.31.
- Hutchmed China Limited Adr (HCM) stock is projected to chart a bullish course in 2040, with an average price target of $0.686, representing an $-95.21% surge from its current level. The forecast ranges from a conservative $0.104 to a sky-high $2.188.
- Our analysts predict Hutchmed China Limited Adr (HCM) to jump -3.94% by 2045, soaring from $10.17 to an average price of $13.75, potentially reaching $12.66. While $10.17 is the low estimate, the potential upside is significant.
- Hutchmed China Limited Adr (HCM) stock is expected to climb by 2050, reaching an average of $8.4224, a $-41.14% jump from its current level. However, a wide range of estimates exists, with high and low targets of $7.7824 and $2.0723, respectively, highlighting the market's uncertainty.
Hutchmed China Limited Adr Stock (HCM) Year by Year Forecast
Hutchmed China Limited Adr Stock (HCM) Price Forecast for 2025
Hutchmed China Limited Adr Stock (HCM) is expected to reach an average price of $18.52 in 2025, with a high prediction of $28.66 and a low estimate of $8.3739. This indicates an +29.40% rise from the last recorded price of $14.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $20.04 | $15.71 | $20.11 | +40.03% |
| February, 2025 | $18.17 | $16.02 | $23.47 | +26.99% |
| March, 2025 | $16.64 | $15.69 | $22.07 | +16.25% |
| April, 2025 | $11.61 | $8.3739 | $19.30 | -18.90% |
| May, 2025 | $13.47 | $10.61 | $13.98 | -5.87% |
| June, 2025 | $16.03 | $14.11 | $16.54 | +12.05% |
| July, 2025 | $17.30 | $13.44 | $18.39 | +20.92% |
| August, 2025 | $22.17 | $17.28 | $23.21 | +54.91% |
| September, 2025 | $25.25 | $19.00 | $26.23 | +76.46% |
| October, 2025 | $28.28 | $24.25 | $28.66 | +97.64% |
| November, 2025 | $26.09 | $25.18 | $28.43 | +82.29% |
| December, 2025 | $23.26 | $22.58 | $28.40 | +62.51% |
Hutchmed China Limited Adr Stock (HCM) Price Forecast for 2026
The predicted value for Hutchmed China Limited Adr (HCM) in 2026 is set at an average of $27.84. Estimates vary from a peak of $38.01 to a trough of $17.67, indicating an +94.53% surge from the present price of $14.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $25.53 | $23.22 | $27.13 | +78.40% |
| February, 2026 | $22.20 | $20.95 | $25.64 | +55.16% |
| March, 2026 | $27.71 | $21.65 | $30.89 | +93.62% |
| April, 2026 | $27.72 | $24.57 | $30.66 | +93.69% |
| May, 2026 | $22.96 | $20.66 | $27.71 | +60.46% |
| June, 2026 | $23.21 | $20.25 | $23.40 | +62.16% |
| July, 2026 | $19.81 | $17.67 | $24.47 | +38.40% |
| August, 2026 | $24.57 | $19.42 | $24.99 | +71.70% |
| September, 2026 | $31.57 | $19.86 | $34.73 | +120.61% |
| October, 2026 | $35.95 | $29.97 | $38.01 | +151.25% |
| November, 2026 | $34.46 | $30.79 | $37.26 | +140.79% |
| December, 2026 | $30.69 | $29.80 | $37.03 | +114.45% |
Hutchmed China Limited Adr Stock (HCM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Hutchmed China Limited Adr (HCM) is $16.86, with a high forecast of $30.94 and a low forecast of $2.7665. This indicates an +17.79% increase from the last price of $14.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $26.31 | $25.52 | $30.94 | +83.87% |
| February, 2027 | $24.90 | $23.41 | $26.65 | +73.97% |
| March, 2027 | $29.18 | $22.25 | $30.56 | +103.88% |
| April, 2027 | $25.30 | $23.87 | $30.51 | +76.80% |
| May, 2027 | $21.07 | $18.89 | $26.00 | +47.26% |
| June, 2027 | $15.85 | $15.28 | $22.68 | +10.79% |
| July, 2027 | $13.23 | $8.7955 | $15.74 | -7.56% |
| August, 2027 | $10.33 | $10.31 | $15.31 | -27.80% |
| September, 2027 | $3.9215 | $2.7665 | $10.63 | -72.60% |
| October, 2027 | $5.4855 | $3.2795 | $6.3495 | -61.67% |
| November, 2027 | $9.9295 | $5.7115 | $10.07 | -30.61% |
| December, 2027 | $8.2995 | $6.0435 | $9.7355 | -42.00% |
Hutchmed China Limited Adr Stock (HCM) Price Forecast for 2028
In 2028, Hutchmed China Limited Adr (HCM) is projected to reach an average price of $8.8914, with a high projection of $15.88 and a low estimate of $1.9014. This indicates an -37.87% fall from the last price of $14.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.3634 | $6.4574 | $8.3855 | -48.54% |
| February, 2028 | $3.3474 | $2.8514 | $8.9654 | -76.61% |
| March, 2028 | $3.3574 | $1.9014 | $3.8634 | -76.54% |
| April, 2028 | $5.2514 | $2.9434 | $6.4254 | -63.30% |
| May, 2028 | $8.6014 | $5.5474 | $9.5814 | -39.89% |
| June, 2028 | $11.92 | $8.4174 | $12.84 | -16.73% |
| July, 2028 | $11.39 | $10.91 | $15.88 | -20.41% |
| August, 2028 | $8.8494 | $7.8994 | $12.25 | -38.16% |
| September, 2028 | $9.3233 | $6.9933 | $9.7813 | -34.85% |
| October, 2028 | $10.63 | $8.7993 | $12.83 | -25.73% |
| November, 2028 | $7.2273 | $6.3891 | $10.81 | -49.49% |
| December, 2028 | $6.7513 | $5.4253 | $9.0093 | -52.82% |
Hutchmed China Limited Adr Stock (HCM) Price Forecast for 2029
The 2029 price forecast for Hutchmed China Limited Adr Stock (HCM) is $11.52 on average, with a high prediction of $16.69 and a low estimate of $6.3573. This represents an -19.47% decrease from the previous price of $14.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.8513 | $6.3573 | $9.7553 | -38.15% |
| February, 2029 | $9.1053 | $7.8793 | $11.30 | -36.37% |
| March, 2029 | $9.5393 | $8.6033 | $10.87 | -33.34% |
| April, 2029 | $13.52 | $10.06 | $13.74 | -5.50% |
| May, 2029 | $13.90 | $11.08 | $15.60 | -2.84% |
| June, 2029 | $13.47 | $12.24 | $14.59 | -5.89% |
| July, 2029 | $13.04 | $11.68 | $14.73 | -8.87% |
| August, 2029 | $7.4612 | $7.3783 | $12.74 | -47.86% |
| September, 2029 | $10.71 | $6.9075 | $11.19 | -25.19% |
| October, 2029 | $11.41 | $8.6432 | $14.41 | -20.30% |
| November, 2029 | $11.54 | $11.11 | $13.17 | -19.36% |
| December, 2029 | $12.06 | $11.74 | $16.69 | -15.72% |
Hutchmed China Limited Adr Stock (HCM) Price Forecast for 2030
Hutchmed China Limited Adr Stock (HCM) is expected to reach an average price of $9.4897 in 2030, with a high forecast of $17.01 and a low forecast of $1.9677. This signifies an -33.68% decrease from the last price of $14.31.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $13.04 | $9.812 | $15.29 | -8.88% |
| February, 2030 | $8.7579 | $7.516 | $16.80 | -38.80% |
| March, 2030 | $6.8959 | $6.1019 | $9.2399 | -51.81% |
| April, 2030 | $8.4789 | $6.0249 | $8.9989 | -40.75% |
| May, 2030 | $4.7739 | $3.4068 | $9.0679 | -66.64% |
| June, 2030 | $6.9119 | $3.8679 | $7.8619 | -51.70% |
| July, 2030 | $10.89 | $5.7938 | $10.99 | -23.92% |
| August, 2030 | $12.62 | $9.2198 | $12.75 | -11.81% |
| September, 2030 | $13.57 | $11.28 | $13.90 | -5.19% |
| October, 2030 | $15.54 | $9.5738 | $17.01 | +8.58% |
| November, 2030 | $7.3657 | $5.6757 | $15.64 | -48.53% |
| December, 2030 | $5.0737 | $1.9677 | $7.0997 | -64.54% |
1.61%
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):